Article Listing - FDA reviews Pradaxa bleeding risk

INDIA; DRUG REVIEW DELAYS POLICY

3 February 1992

A new review of the drug products which are to remain under government price control is reportedly causing delay in...

MOZAMBIQUE HEALTH CARE

3 February 1992

A bill allowing the establishment of a private health care sector in Mozambique for the first time since 1975 is...

HOECHST ATTACKED OVER MIFEPRISTONE

3 February 1992

Hoechst Celanese Corp, a US subsidiary of Hoechst-AG, one of the companies behind the manufacturers of the controversial abortifacient drug...

ADVANCE IN DIABETES RESEARCH

3 February 1992

Diabetes researchers at the University of Texas Southwestern Medical Center, Dallas, USA, have taken a first step towards the creation...

ENZON AND ALLELIX IN EGF DEAL

3 February 1992

Enzon has signed an agreement with Allelix Biopharmaceuticals for the development of a modified version of epidermal growth factor, using...

CIBA-GEIGY SEEKS US SELF-MED COMPANY

3 February 1992

Ciba-Geigy's intention to move decisively to take advantage of current expansion of the self-medication market is reflected in its active...

US APPROVAL FOR SB'S TRIOSTAT

3 February 1992

- SmithKline Beecham has received approval from the US Food and Drug Administration to market Triostat (tri-iodothyronine) its orphan drug...

SOLCO'S UTI PRODUCT EFFECTIVE

3 February 1992

- Swiss pharmaceutical concern Solco's immunomodulator product SolcoUrovac has been found to be 71% effective in preventing recurrent urinary tract...

FOREST LAB'S ROBIN BURROWS RETIRES

3 February 1992

- Robin Burrows has resigned as vice president of corporate development with Forest Labor-atories Inc, and is presently acting as...

NEW DIRECTOR AT INSALUD

3 February 1992

- Antolin Rodriguez Martinez has been appointed as director of Spain's national institute for health, Insalud.

Showing 94851-94860 of 95333 articles